Krystal Biotech (KRYS) Revenue (2016 - 2026)
Krystal Biotech (KRYS) revenue from Sep 30, 2016 to Mar 31, 2026. The TTM Krystal Biotech (KRYS) revenue is $417M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Krystal Biotech (KRYS) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +25.15% |
Annual Revenue change of Krystal Biotech (KRYS)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $116M | -70.10% |
| 2025 | $389M | +33.94% |
| 2024 | $291M | +473.02% |
| 2023 | $51M | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |